Related Experiment Videos
Isoxsuprine and the rat abdominal pedicle flap: a controlled study
British Journal of Plastic Surgery
|October 1, 1981
Summary
Isoxsuprine did not reduce flap necrosis in a rat study. Placebo treatment resulted in significantly less necrosis compared to isoxsuprine, indicating potential adverse effects of the drug.
Area of Science:
- Plastic Surgery
- Surgical Research
- Tissue Engineering
Background:
- Flap necrosis is a significant complication in reconstructive surgery.
- Isoxsuprine, a vasodilator, has been investigated for potential benefits in improving flap survival.
- Controlled studies are essential to validate therapeutic efficacy.
Purpose of the Study:
- To evaluate the effect of isoxsuprine treatment on reducing flap necrosis in a rat abdominal pedicle flap model.
- To compare the outcomes of isoxsuprine treatment versus placebo in preventing flap necrosis.
Main Methods:
- A controlled study was conducted using a rat abdominal pedicle flap model.
- Animals were randomized to receive either isoxsuprine or saline placebo injections.
- The area of flap necrosis was quantified and compared between groups.
Main Results:
- Isoxsuprine treatment did not lead to a reduction in the area of flap necrosis.
- Animals receiving placebo injections exhibited significantly less flap necrosis than those treated with isoxsuprine.
- The results suggest a potential detrimental effect of isoxsuprine on flap survival in this model.
Conclusions:
- Isoxsuprine is ineffective in reducing flap necrosis in the rat abdominal pedicle flap model.
- The study indicates that isoxsuprine may exacerbate flap necrosis, contrary to potential therapeutic expectations.
- Further research is warranted to understand the mechanisms behind isoxsuprine's effect on tissue viability.